Home » Amgen Buying Turkey’s Mustafa Nevzat for $700 Million
Amgen Buying Turkey’s Mustafa Nevzat for $700 Million
Amgen is buying Turkish pharmaceutical company Mustafa Nevzat Pharmaceuticals for $700 million as part of its international expansion plans.
Businessweek
Businessweek
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May